tDCS + Speech Therapy for Aphasia
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine if mild electrical stimulation, combined with speech therapy, can improve language recovery for individuals with aphasia after a stroke. The study includes different groups testing combinations of targeted and active control electrical stimulation (Transcranial Direct Current Stimulation, or tDCS) with two types of speech therapy: phonologic-focused and semantic-focused. Individuals who have experienced a stroke or similar brain injury and have language difficulties might be suitable participants, especially if they are comfortable with MRI scans. As an unphased trial, this study provides a unique opportunity to contribute to innovative research that could enhance language recovery methods.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What prior data suggests that this method is safe for people with post-stroke aphasia?
Research has shown that transcranial Direct Current Stimulation (tDCS) is generally safe. tDCS uses mild electrical currents to stimulate the brain and is both noninvasive and painless. It has been used without causing serious side effects or brain injury. Some people might feel mild itching or burning on their skin, but these effects are not serious.
When combined with speech therapy, as in this study, tDCS may help stroke patients recover language skills. This suggests that the treatment is well-tolerated, even when used in different ways.
Overall, both targeted tDCS and active control tDCS treatments appear safe. They have been tested in various settings, showing they can be used without major safety concerns.12345Why are researchers excited about this trial?
Researchers are excited about combining transcranial direct current stimulation (tDCS) with speech therapy for aphasia because it offers a novel approach compared to traditional speech therapy alone. While standard treatments focus solely on language exercises, tDCS uses a mild electrical current to stimulate specific brain areas, potentially enhancing the brain's ability to recover language functions. This method could accelerate and improve the effectiveness of speech therapy by directly targeting underlying neural pathways. By exploring both phonologic-focused and semantic-focused speech therapy, this approach could provide tailored interventions that address different aspects of language recovery.
What evidence suggests that this trial's treatments could be effective for aphasia?
Research shows that transcranial direct current stimulation (tDCS) can help people with aphasia, a language problem after a stroke, improve their language skills. Studies suggest that combining tDCS with speech therapy enhances the effectiveness of the therapy. In this trial, participants will receive either targeted tDCS or active control tDCS, each paired with phonologic-focused or semantic-focused speech therapy. Both specific and general types of tDCS have shown promise in helping patients regain language abilities. Specifically, anodal tDCS, which uses a gentle electrical current, has been tested and found to enhance the benefits of language therapy. This treatment stimulates brain areas involved in speech and language. Early research indicates it might be a useful tool for those struggling with language after a stroke.23467
Who Is on the Research Team?
Sara Pillay, Ph.D
Principal Investigator
Medical College of Wisconsin
Are You a Good Fit for This Trial?
This trial is for adults who have language difficulties due to brain damage like a stroke. They must speak English fluently and be able to undergo an MRI scan. People with advanced neurodegenerative diseases, severe psychiatric conditions, uncorrectable hearing or vision issues, developmental disabilities, or contraindications to MRI are not eligible.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive targeted or active-control anodal-tDCS with speech therapy for 10 therapy sessions
Crossover Treatment
Participants crossover to receive the alternative tDCS intervention within the same speech therapy arm
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Active Control Transcranial Direct Current Stimulation
- Targeted Transcranial Direct Current Stimulation
Find a Clinic Near You
Who Is Running the Clinical Trial?
Medical College of Wisconsin
Lead Sponsor